Recurrent Cytokine Storm in SARS-CoV-2 Infected Patients with Hematolymphoid Malignancy: A New Perspective
Sujeet Kamtalwar,
Sumeet Mirgh,
Ashwini More,
Palak Sharma,
Nikhil Patkar,
Sweta Rajpal,
Gaurav Chatterjee,
Nitin Shetty,
Anant Gokarn
Affiliations
Sujeet Kamtalwar
Department of General Medicine, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National Institute (HBNI), Maharashtra, India
Department of Medical Oncology, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National institute (HBNI), Maharashtra, India
Ashwini More
Department of General Medicine, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National Institute (HBNI), Maharashtra, India
Palak Sharma
Department of Medical Administration, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National institute (HBNI), Maharashtra, India
Nikhil Patkar
Department of Hematopathology Laboratory, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National institute (HBNI), Maharashtra, India
Sweta Rajpal
Department of Hematopathology Laboratory, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National institute (HBNI), Maharashtra, India
Gaurav Chatterjee
Department of Hematopathology Laboratory, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National institute (HBNI), Maharashtra, India
Nitin Shetty
Department of Radiodiagnosis, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National institute (HBNI), Maharashtra, India
Anant Gokarn
Department of Medical Oncology, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National institute (HBNI), Maharashtra, India
